1 Blood chemistry Peripheral blood Viral marker TP 5.4 g dl WBC 4.310 3 ml Syphilis TPAb Alb 2.7 g dl RBC30210 4 ml HBsAg T. bil 2.3 mg dl Hb 11 g dl



Similar documents
2010 年 6 月 25 表 身体所見 134 cm 31 kg /60 mmhg 83/ ,

BUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI

125 2 P 1st washout 2 PB P mg/dL nd washout 2 P 5.5mg/dL< mg/dL <2.5mg/dL P P 2 D D 3 Ca 10

387 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )

untitled

/12/28 UP 3+, TP 4.2g/dl, Alb 1.9g/dl PSL 50mg/day 1/17 PSL 45mg/day PSL 2006/4/4 PSL 30mg/day mpsl mpsl1000mg 3 2 5/ :90 / :114/64 mmhg


37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate

日本呼吸器学会雑誌第48巻第6号

SBP hospitalist network.key

デスフルラン

日本呼吸器学会雑誌第44巻第10号

WBC 5700 / l Gran 58.5% Lym 29.0% Eosin 0.3% RBC 499x10 6 / l Hb 14.8 g/dl Hct 44.40% PLT 15.3x10 3 / l PT 157% Fbg 616 mg/dl DD 0.99 g/ml GOT GPT LDH

慈大呼吸器_25-1_02T_CS5.indd

1 2 2 ANCA pouci immune IgG C3 ANCA 68 '01 '02 7 UN 14mg/dl, Cr 0.7 mg/dl, -, - ' UN 45mg/dl, Cr 2.4 mg/dl, Ht 29.5%, 4+, cm 61

mg 8 mg X Cr 9.84 mg/ dl K 1.5 meq/l CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml AKI 2 IHD IHD 4 IHD

<4D F736F F D F8DCC97918C7B82CC8C8C897490B689BB8A AB8FF382CC908488DA2E646F63>

総合_H1-H4_1810

九州支部卒後研修会症例

72 20 Ope / class Alb g/ cm 47.9kg : /min 112/60m

Sample2 g/dl Target1 : 6.01 g/dl TP Target2 : 8.39 g/dl

日本呼吸器学会雑誌第44巻第1号


051


日本呼吸器学会雑誌第44巻第6号

08症例報告4山内.indd

<8C9F8DB85F3338E4508CB495612E786C73>

VOL.39 S-3

血糖高いのは朝食後のため検査項目 下限値上限値 単位名称 9 月 3 日 9 月 6 日 9 月 15 日 9 月 18 日 9 月 21 日 9 月 24 日 9 月 28 日 10 月 1 日 10 月 3 日 10 月 5 日 10 月 9 日 10 月 12 日 10 月 15 日 10 月

C033** of 7 C034** PEG-IFN-2b + IFN -2b + 78 HCV-RNA PEG-IFN-2b IFN-2b n=250 n=200 n= =10 % % 85 % 74 % %

日本呼吸器学会雑誌第44巻第7号

日本呼吸器学会雑誌第47巻第6号

生化学検査 臨床検査基準値一覧 近畿大学病院 (1) 検査項目 基準値 単位 検査項目 基準値 単位 CRP mg/dl WBC /μl Na mmol/l M RBC K mmol/l F 3.86-

当院の血液検査室の概要 血液検査 system 自動血球分析装置塗抹標本作製装置 La-vietal LS (Sysmex 社 ) XN-3000 (Sysmex 社 ) XN 台 ( RET WPC PLT-F の各チャンネル ) XN 台 SP-10 (Sysmex

1) Urlne analysls 7)Serologlcal exam. 1 1)ECG W.N.L. sugar 0% CRP (-) urobillnogen N(+) RA (+) 12)Renal function albumin 3(+) ASLO (-) PSP test 15' 40

ONS60409_gencyo.indd

生活設計レジメ

44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)

I II III 28 29



Microsoft Word - 第2回海外勤務健康管理抄録の表紙他.doc

_”÷’X


Valganciclovir 1 CMV valganciclovir VGCV CMV IgM CMV-DNA CMV 34 VGCV 2 1 CMV CMV ganciclovir valganciclovir MRI cytomegaloviru

頸部リンパ節腫張 のコピー.pptx

温泉の化学 1

Microsoft PowerPoint - 当日H3001標準化報告会用hiramitu.pptx

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio

BAANs理論に基づく保健指導プログラム暫定版

59 20 : 50 : : : : : 2 / :20 / 25 GTP /28 5/3 5/4 5/8 6/1 1 7kg 6/9 :178.7cm :68.55kg BMI:21.47 :37.3 :78 / :156/78mmHg 1


T08816renketsu.indb

小児感染免疫第29巻第2号

日本消化器外科学会雑誌第29巻第9号

JC44104


untitled

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec LVFX 100 mg 3 / mg 2 / LVFX PK PD mg mg 1 1 AUC/MIC

Ⅱ Hb 4.1g/dl S LST G S ESD 10 S S 4 4 S D mL tub1 muc SS ly0 v0 PM0 DM0 N0 0/27 S tub1 tub2 SS

Transcription:

2012; 18: 200 207 Necropsy 1 1 1 2 65 11 autoimmune hepatitisaih 14 21 1 5 13 Necropsy CHF1 A1 Kupffer cell hemosiderin Berlin blue KEY WORDS: hemochromatosis, autoimmune hepatitis, liver cirrhosis, necropsy Ayada M 1, Hotta N 1, Kurokawa T 2 : A case of autoimmune hepatitis diagnosed with iron overload disease in the necropsy. JJPH 2012; 18: 200 207 I. autoimmune hepatitisaih 11 necropsy 1 AIH II. 65 11 AIH 14 Child- Pugh Grade B AIH 1 453-0016 35-28 2 453-0016 35-28 1 Department of Hepato-Gastroenterology, Masuko Memorial Hospital, 35-28 Takebashi Nakamura-ku Nagoya-shi, Aichi, 453-8566 Japan 2 Department of Surgery, Division of Hepato-Gastroenterology, Masuko Memorial Hospital, 35-28 Takebashi Nakamura-ku Nagoyashi, Aichi, 453-8566 Japan 18 2011 2012 2 2 2012 7 31 300 mg 40 mg 25 mg 20 12 80 mg 50 mg 120 mg 21 1 18 8 Red Cells ConcentratesRCC5 149 cm 44 Kg 36.2 100 82 mmhg 86 SATO 2 96 200

1 Blood chemistry Peripheral blood Viral marker TP 5.4 g dl WBC 4.310 3 ml Syphilis TPAb Alb 2.7 g dl RBC30210 4 ml HBsAg T. bil 2.3 mg dl Hb 11 g dl HBsAb GOT 52 IU l Ht 32.2 HCVAb GPT 41 IU l Plt 4.210 4 ml Blood gas analysis LDH 414 IU l Differential white blood count ph 7.506 ALP 440 IU l Neutro 79.2 PO2 70.2 mmhg g-gtp 13 IU l Eosino 0 PCO2 32.2 mmhg AMY 98 IU l Lymph 11.8 HCO3 24.9 mmoll BUN 50 mg dl Mono 8.1 SATO2 97.8 Cr 1.03 mg dl Baso 0.9 Na 131 meq l Coagulation K 4.3 meq l PT 49 Cl 99 meq l HPT 56 glu 112 mg dl Tumor marker UA 6.1 mg dl AFP 3.7 ng mlnormal range0.0 16.5 T. cho 150 mg dl PIVKA 19 mau mlreference value 40 CRP 0.1 mg dl Autoantibody ANA 2560 timesreference value 40 AMA negative 1 X-P 1Hb 11 g dl Plt 4.210 4 ml Alb 2.7 g dl T. bil 2.3 mg dl, AST 52 mg dl, ALT 41 mg dl, LDH 414 mg dl, ALP 440 mg dlg-gpt 13 mg dl 49 56 2560 40 room airph7.506, 2012; 18: 200 207 201

2 CT CT 70 HUHounsfield unit 3 CT 202 2012; 18: 200 207

Lm, F1, Cb, RC 0 Lg PHG 4 PO270.2 mmhg, PCO232.2 mmhg, HCO324.9 mmol l, SATO297.8 X-P 1 CT 2 CT 3 CT 70 HUHounsfield unit 4 Lm, F1, Cb, RC 0 Lg PHG 5 4 necropsy 6 8Hematoxylin-eosin Kupffer hemosiderin Azan CHF1 A1Berlin blue Kupffer bridging fibrosis AIH III. AIH 1 3 NASH GIgG 2012; 18: 200 207 203

4 necropsy 5 1 3 AIH IgG AIH 1999 13 2008 4 AIH 1996 2560 5 3 AIH CT AIH 4 6 4 2 7, 8 204 2012; 18: 200 207

AHematoxylin-eosin stain BAzan stainchf1 CBerlin blue stain Berlin blue 640 A100CHA1 B200 hemosiderin 7Hematoxylin-eosin stain 7, 13 C NASH 4, 9 13 AIH Kupffer 2012; 18: 200 207 205

A100 Berlin blue B, C200 Kupffer 8Berlin blue stain 2, 14 hepcidin 4 6, 15 C hepcidin hepcidin 16 18 necropsy Kupffer Kupffer C hepcidin 2 RCC 5 10 13, 18 CT 19 CT 22 72 HU 72 HU 20 CT 70 HU 2, 21, 22 21 adenosine triphosphate ATP 3 2 2 Fenton 206 2012; 18: 200 207

2, 21 23 AIH AIH bridging fibrosis 24 24 AIH necropsy hemosiderin F1 A1 AIH 1 necropsy AIH 25, 26 necropsy AIH AIH IV. necropsy 1 1 2010; 105: 986991 2 1 2006; 47: 341346 3 2009; 50: 618625 4 2011; 100: 24122424 5 2007; 48: 3645 6 hepcidin. BIO Clinica 2006; 21: 350354 7 1998; 20: 493494 8 Zone 1 2007; 55: 8391 9 1 2008; 49: 574580 10 MDS PBC 1 2007; 44: 148151 11 refractory anemia with ringed siderblasts (RARS 1 1993; 71: 363366 12 myelodysplastic syndrome 1 1986; 75: 14381442 13 1986; 44: 18791891 14 Kyosuke Kaji, Yasuni Nakamura, Motoko Sasaki, et al: Hemosiderin Deposition in Portal Endotherial Cells. Human Pathology 1995; 26: 10801085 15 2005; 214: 11: 945948 16 Naoki Fujita, Ryosuke Sugimoto, Masaki Takeo, et al: Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C. Mol Med 2007; 13: 97 104 17 Naoki Fujita, Ryosuke Sugimoto, Satoshi Motonishi, et al: Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion. J Hepatol 2008; 49: 702710 18 2009; 39: 418425 19 1979; 20: 1435 1439 20 Howard JM, Ghent CN, Carey LS, et al: Diagnostic efficacy of hepatic computed tomography in the detection of body iron overload. Gastroenterology 1983; 84: 209215 21 2006; 52: 875885 22 2003; 47: 489495 23 Reddy MB, Clark L: Iron, oxidative stress, and disease risk. Nutrition Reviews 2004; 62: 120124 24 BIO Clinica 2010; 25: 264268 25 2011; 108: 18231836 26 2005; 102: 1724 2012; 18: 200 207 207